Ashton Thomas Private Wealth’s Plus Therapeutics PSTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$150K Buy
34,306
+32,989
+2,505% +$180K ﹤0.01% 1203
2026
Q1
$5.35K Buy
1,317
+320
+32% +$2.43K ﹤0.01% 1442
2025
Q4
$12.8K Buy
+997
New +$15K ﹤0.01% 996
2024
Q4
Sell
-517
Closed -$18.9K 807
2024
Q3
$18.9K Buy
517
+484
+1,467% +$19.1K ﹤0.01% 614
2024
Q2
$1.2K Buy
+33
New +$1.62K ﹤0.01% 1827
2023
Q2
Sell
-33
Closed -$3.55K 595
2023
Q1
$3.55K Hold
33
﹤0.01% 495
2022
Q4
$3.88K Hold
33
﹤0.01% 471
2022
Q3
$5.44K Hold
33
﹤0.01% 445
2022
Q2
$6.61K Buy
+33
New +$8.24K ﹤0.01% 448

Other funds holding PSTV

Ashton Thomas Private Wealth's PSTV Position: Q2 2026 in Review

Ashton Thomas Private Wealth increased its Plus Therapeutics (PSTV) stake by 2,505% in Q2 2026, buying an estimated $180K and bringing the position to 34,306 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #1203.

Ashton Thomas Private Wealth first reported a position in PSTV in Q2 2022 and has held it in 9 quarters since. 4 funds tracked by Wall St. Rank hold PSTV as of Q2 2026.

  • Ashton Thomas Private Wealth held 34,306 shares of Plus Therapeutics worth $150K as of Q2 2026.
  • Ashton Thomas Private Wealth bought 32,989 Plus Therapeutics shares in Q2 2026, an estimated $180K.
  • Plus Therapeutics made up ﹤0.01% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #1203 holding.
  • Ashton Thomas Private Wealth first reported a position in Plus Therapeutics in Q2 2022 and has held it in 9 quarters since.
  • 4 funds tracked by Wall St. Rank held Plus Therapeutics as of Q2 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.